Clinical trials
Terminated Phase 1 Leukemia, Myeloid, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
202 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 9 |
| 2008 | 5 |
| 2009 | 8 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 13 |
| 2015 | 9 |
| 2016 | 19 |
| 2017 | 13 |
| 2018 | 17 |
| 2019 | 13 |
| 2020 | 17 |
| 2021 | 16 |
| 2022 | 14 |
| 2023 | 10 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 202 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 10 |
| National Cancer Institute (NCI) | 9 |
| AbbVie | 7 |
| Amgen | 6 |
| Celgene | 6 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 5 |
| University of Pennsylvania | 5 |
| AstraZeneca | 4 |
| Daiichi Sankyo | 3 |
| Merck Sharp & Dohme LLC | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 202 |
| Myelodysplastic Syndromes | 56 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 38 |
| Leukemia | 37 |
| Recurrence | 32 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 23 |
| Lymphoma, Non-Hodgkin | 22 |
| Multiple Myeloma | 21 |
| Congenital Abnormalities | 19 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 17 |
Trials
Showing 1 to 25 of 202. Each trial links to its page on Pharma Observatory.
102 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.